Jason Amello - Sep 21, 2022 Form 3 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Chief Financial Officer
Signature
/s/ Jason A. Amello
Stock symbol
CADL
Transactions as of
Sep 21, 2022
Transactions value $
$0
Form type
3
Date filed
9/23/2022, 04:10 PM
Previous filing
Jan 19, 2022
Next filing
Nov 30, 2022

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney No securities are beneficially owned.